Bernstein Liebhard LLP Launches Zofran Lawsuit Website in Response to Recent Litigation Involving Anti-Nausea Medication

News provided by

Feb 24, 2015, 02:09 ET

NEW YORK, Feb. 24, 2015 /PRNewswire/ -- The nationwide law firm of Bernstein Liebhard LLP announces the launch of a new Zofran lawsuit (http://www.zofranlawsuit2015.com/ ) website to keep the public informed about pending litigation involving the anti-nausea medication. The Firm intends that the site will provide information on the process for filing similar claims on behalf of children who were allegedly born with serious birth defects due to their mother's use of Zofran during pregnancy.

"At least two Zofran lawsuits have been filed in federal courts this month that allege off-label use of the medication to treat nausea and vomiting related to pregnancy caused babies to be born serious heart birth defects. These claims both cite evidence suggesting the use of Zofran in pregnancy may increase the risk of birth defects, including heart defects." says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Zofran case evaluations to any family whose child was allegedly born with a serious birth defect due to pre-natal exposure to this medication.

Zofran Allegations

Zofran, known generically as ondansetron, is approved to treat post-operative nausea and vomiting, as well as nausea and vomiting related to certain types of chemotherapy and radiography.* On February 12, 2014, court records show that a Zofran lawsuit was filed in U.S. District Court, Eastern District of Pennsylvania by a woman who alleges her use during both of her pregnancies in 2004 and 2006 caused her two children to be born with serious heart abnormalities. (Case 2:15-cv-00709-PD) On February 16, 2015, a second complaint was filed in the U.S. District Court, District of Massachusetts on behalf of a child who was allegedly born with several congenital heart abnormalities, including atrial septal defect, right ventricular hypertension and aortic arch hypoplasia, due to the mother's use of Zofran during the first trimester of pregnancy. (Case 1:15-cv-10429)

According to court documents, both of these lawsuits point out that Zofran was never approved to treat nausea and vomiting in expectant mothers, and that its safety during pregnancy has not been well studied. Both complaints also site studies that investigated the possible association between ondansetron and birth defects, including research from 2013 that drew data from more than 900,000 pregnancies included in a Danish health registry. That study indicated that women who were exposed to the medication during pregnancy were more likely to give birth to a child with birth defects.** Both lawsuits also note that in 2012, GlaxoSmithKline agreed to pay $3 billion to resolve charges with the U.S. Department of Justice regarding the marketing of a number of medications. Among other things, the company had been accused of improperly marketing Zofran as a treatment for nausea and vomiting in pregnancy.

Parents of children who were born with serious birth defects allegedly related to their mother's use of Zofran during pregnancy may be entitled to file their own claims against GlaxoSmithKline. To find out more about available legal options, please visit Bernstein Liebhard LLP's website, or call the Firm directly at (888) 340-4807.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(888) 340-4807

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (888) 340-4807. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.zofranlawsuit2015.com/

https://plus.google.com/115936073311125306742?rel=author

Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

SOURCE Bernstein Liebhard LLP